Candida albicans strain-dependent modulation of pro-inflammatory cytokine release by in vitro oral and vaginal mucosal models

Cytokine

Volumn 57, Issue 1, 2012, Pages 89-97

  Whiley, Robert A ^a   Cruchley, Alan T ^a   Gore, Carelyn ^a   Hagi Pavli, Eleni ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Candida albicans; Epithelium; Inflammatory cytokines; Oral; Vaginal

Indexed keywords

ASPARTIC PROTEINASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHOLIPASE; PROSTAGLANDIN E2;

ADHESION; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FUNGAL VIRULENCE; FUNGUS HYPHAE; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MOUTH INFECTION; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; STOMATITIS; STRAIN DIFFERENCE; VAGINA MUCOSA;

ADHESIVENESS; ASPARTIC ACID ENDOPEPTIDASES; CANDIDA ALBICANS; CYTOKINES; DINOPROSTONE; EPITHELIUM; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MODELS, BIOLOGICAL; MOUTH MUCOSA; PHOSPHOLIPASES; VAGINA;

CANDIDA ALBICANS;

EID: 84155160719     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.10.017     Document Type: Article

References (54)

1. Arendorf T.M., Walker D.M. The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 1980, 25:1-10.
2. Calderone R.A., Fonzi W.A. Virulence factors of Candida albicans. Trends Microbiol 2001, 9:327-335.
3. Fanello S., Bouchara J.P., Sauteron M., Delbos V., Parot E., Marot-Leblond A., et al. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J Med Microbiol 2006, 55:223-228.
4. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Int J Gynaecol Obstet 2000, 71 Suppl 1:21-27.
5. Grubb S.E., Murdoch C., Sudbery P.E., Saville S.P., Lopez-Ribot J.L., Thornhill M.H. Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect Immun 2008, 76:4370-4377.
6. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Hollis R.J., Messer S.A. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 1998, 36:1886-1889.
7. Richardson M.D. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005, 56 Suppl 1:5-11.
8. Calderone R.A., Braun P.C. Adherence and receptor relationships of Candida albicans. Microbiol Rev 1991, 55:1-20.
9. Cutler J.E. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991, 45:187-218.
10. Naglik J.R., Challacombe S.J., Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003, 67:400-428. table of contents.
11. Rosa E.A., Rached R.N., Ignacio S.A., Rosa R.T., Jose da Silva W., Yau J.Y., et al. Phenotypic evaluation of the effect of anaerobiosis on some virulence attributes of Candida albicans. J Med Microbiol 2008, 57:1277-1281.
12. Sandini S., La Valle R., De Bernardis F., Macri C., Cassone A. The 65 kDa mannoprotein gene of Candida albicans encodes a putative beta-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity. Cell Microbiol 2007, 9:1223-1238.
13. Schmid J., Hunter P.R., White G.C., Nand A.K., Cannon R.D. Physiological traits associated with success of Candida albicans strains as commensal colonizers and pathogens. J Clin Microbiol 1995, 33:2920-2926.
14. Vazquez J.A., Sanchez V., Dmuchowski C., Dembry L.M., Sobel J.D., Zervos M.J. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993, 168:195-201.
15. 3. J Clin Microbiol 1999, 37:2817-2828.
16. Voss A., Hollis R.J., Pfaller M.A., Wenzel R.P., Doebbeling B.N. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994, 32:975-980.
17. Tavanti A., Davidson A.D., Fordyce M.J., Gow N.A., Maiden M.C., Odds F.C. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J Clin Microbiol 2005, 43:5601-5613.
18. Eversole L.R., Reichart P.A., Ficarra G., Schmidt-Westhausen A., Romagnoli P., Pimpinelli N. Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997, 84:372-380.
19. Schaller M., Mailhammer R., Grassl G., Sander C.A., Hube B., Korting H.C. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002, 118:652-657.
20. Samaranayake Y.H., Samaranayake L.P. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001, 14:398-429.
21. Pivarcsi A., Nagy I., Koreck A., Kis K., Kenderessy-Szabo A., Szell M., et al. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microbes Infect 2005, 7:1117-1127.
22. Jayatilake J.A., Samaranayake Y.H., Samaranayake L.P. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Pathol Med 2005, 34:240-246.
23. Jayatilake J.A., Samaranayake Y.H., Cheung L.K., Samaranayake L.P. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol Med 2006, 35:484-491.
24. Bartie K.L., Williams D.W., Wilson M.J., Potts A.J., Lewis M.A. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol 2004, 19:293-296.
25. Schaller M., Schafer W., Korting H.C., Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 1998, 29:605-615.
26. Schaller M., Korting H.C., Schafer W., Bastert J., Chen W., Hube B. Secreted aspartic proteinase (SAP) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 1999, 34:169-180.
27. Bernhardt J., Herman D., Sheridan M., Calderone R. Adherence and invasion studies of Candida albicans strains, using in vitro models of esophageal candidiasis. J Infect Dis 2001, 184:1170-1175.
28. Bonowitz A., Schaller M., Laude J., Reimer K., Korting H.C. Comparative therapeutic and toxic effects of different povidone iodine (PVP-I) formulations in a model of oral candidosis based on in vitro reconstituted epithelium. J Drug Target 2001, 9:75-83.
29. Ghannoum M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000, 13:122-143. table of contents.
30. Borst A., Fluit A.C. High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections. J Med Microbiol 2003, 52:971-974.
31. Schaller M., Korting H.C., Borelli C., Hamm G., Hube B. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 2005, 73:2758-2765.
32. Kumar C.P., Kumar S.S., Menon T. Phospholipase and proteinase activities of clinical isolates of Candida from immunocompromised patients. Mycopathologia 2006, 161:213-218.
33. Price M.F., Wilkinson I.D., Gentry L.O. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982, 20:7-14.
34. Steele C., Fidel P.L. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002, 70:577-583.
35. Steele C., Leigh J., Swoboda R., Fidel P.L. Growth inhibition of Candida by human oral epithelial cells. J Infect Dis 2000, 182:1479-1485.
36. Nomanbhoy F., Steele C., Yano J., Fidel P.L. Vaginal and oral epithelial cell anti-Candida activity. Infect Immun 2002, 70:7081-7088.
37. Dongari-Bagtzoglou A., Kashleva H. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 2003, 34:169-177.
38. Mostefaoui Y., Bart C., Frenette M., Rouabhia M. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-α expression and secretion by engineered human oral mucosa cells. Cell Microbiol 2004, 6:1085-1096.
39. Mostefaoui Y., Claveau I., Rouabhia M. In vitro analyses of tissue structure and interleukin-1beta expression and production by human oral mucosa in response to Candida albicans infections. Cytokine 2004, 25:162-171.
40. Saavedra M., Taylor B., Lukacs N., Fidel P.L. Local production of chemokines during experimental vaginal candidiasis. Infect Immun 1999, 67:5820-5826.
41. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-150.
42. Deva R., Shankaranarayanan P., Ciccoli R., Nigam S. Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B. J Immunol 2003, 171:3047-3055.
43. Kalo-Klein A., Witkin S.S. Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infect Immun 1990, 58:260-262.
44. Rosdy M., Bernard B.A., Schmidt R., Darmon M. Incomplete epidermal differentiation of A431 epidermoid carcinoma cells. In vitro Cell Dev Biol 1986, 22:295-300.
45. Pietrella D., Rachini A., Pandey N., Schild L., Netea M., Bistoni F., et al. The inflammatory response induced by aspartic proteases of Candida albicans is independent of proteolytic activity. Infect Immun 2010, 78:4754-4762.
46. Hannula J., Saarela M., Dogan B., Paatsama J., Koukila-Kahkola P., Pirinen S., et al. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol Immunol 2000, 15:238-244.
47. Kadir T., Gumru B., Uygun-Can B. Phospholipase activity of Candida albicans isolates from patients with denture stomatitis: the influence of chlorhexidine gluconate on phospholipase production. Arch Oral Biol 2007, 52:691-696.
48. Malic S., Hill K.E., Ralphs J.R., Hayes A., Thomas D.W., Potts A.J., et al. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy. Oral Microbiol Immunol 2007, 22:188-194.
49. Ibrahim A.S., Mirbod F., Filler S.G., Banno Y., Cole G.T., Kitajima Y., et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995, 63:1993-1998.
50. Koga-Ito C.Y., Lyon J.P., Vidotto V., de Resende M.A. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia 2006, 161:219-223.
51. Samaranayake L.P., Raeside J.M., MacFarlane T.W. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984, 22:201-207.
52. Hernandez R., Rupp S. Human epithelial model systems for the study of Candida infections in vitro: part II. Histologic methods for studying fungal invasion. Methods Mol Biol 2009, 470:105-123.
53. Schaller M., Weindl G. Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia for the study of host-pathogen interactions. Methods Mol Biol 2009, 470:327-345.
54. Steele C., Ozenci H., Luo W., Scott M., Fidel P.L. Growth inhibition of Candida albicans by vaginal cells from naive mice. Med Mycol 1999, 37:251-259.